Device Trial Radar · NCT03966768
DuraMesh Laparotomy Study
Last checked: Nov 20, 2026Latest source record: Sep 13, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Withdrawn
Enrollment
0
Actual
Start
Oct 15, 2023
Primary completion
Dec 31, 2024
Study completion Dec 31, 2025
Sponsor
- Lead sponsor
- Mesh Suture Inc.Not on our public-company list
- Sponsor type
- Industry
- Collaborators
- Uniformed Services University of the Health Sciences; Walter Reed National Military Medical Center; University of Maryland
- First posted
- May 29, 2019
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a multisite randomized control proof-of-concept trial to evaluate the safety of Duramesh laparotomy closure in the trauma and emergency laparotomy setting. The study will be performed at University of Maryland Shock Trauma Center and Walter Reed National Military Medical Center. One hundred (100) patients will be randomized (2:1) to Duramesh laparotomy closure versus conventional suture closure. After the patient has been confirmed to be a candidate for the trial, randomization will be performed in the operating room upon completion of the index abdominal procedure. Duramesh will be provided for patients assigned to the Duramesh treatment arm. Patients will be followed for 1 year following laparotomy closure at follow-up intervals of 1 month, 3 months, 6 months, and 12 months.
Conditions
- Laparotomy
- Suture; Complications, Mechanical
- Hernia Incisional
Interventions
Duramesh suturable mesh for laparotomy closureDevice
Patients undergoing laparotomy will be closed with Duramesh suturable mesh
Conventional suture for laparotomy closureDevice
Patients undergoing laparotomy will be closed with conventional polydiaxonone suture
Primary outcomes
What the sponsor says the trial is designed to measure.
- Surgical site infectionTime frame: 1 month
- Surgical site infectionTime frame: 3 months
- Surgical site infectionTime frame: 6 months
1 more outcomes with a free account
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.